+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhalers & Nebulizers Market by Device Type, Therapeutic Class, Distribution Channel, End User, Indication - Global Forecast to 2030- Product Image
Inhalers & Nebulizers Market by Device Type, Therapeutic Class, Distribution Channel, End User, Indication - Global Forecast to 2030- Product Image
Sale

Inhalers & Nebulizers Market by Device Type, Therapeutic Class, Distribution Channel, End User, Indication - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4858009
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The inhalers and nebulizers market is entering a phase of rapid transformation, shaped by continual innovation, shifting regulatory requirements, and evolving patient expectations. Senior leaders must understand the market dynamics to anticipate opportunities and address emerging risks.

Market Snapshot of the Inhalers & Nebulizers Market

The inhalers and nebulizers market grew from USD 11.45 billion in 2024 to USD 14.08 billion in 2025. With a forecast CAGR of 22.50%, the sector is on track to reach USD 38.72 billion by 2030. This robust momentum reflects increased adoption of advanced devices, technological integration, and expanding therapeutic applications across key global regions.

Scope & Segmentation of the Inhalers & Nebulizers Market

  • Device Types: Includes dry powder inhalers, metered dose inhalers, soft mist inhalers, jet nebulizers, mesh nebulizers, and ultrasonic nebulizers, serving a variety of administration preferences and clinical conditions.
  • Therapeutic Classes: Anticholinergics, bronchodilators (long-acting and short-acting beta-2 agonists), combination drugs (ICS LABA, ICS LABA LAMA, LABA LAMA), corticosteroids, and mucolytics, supporting tailored respiratory care regimens.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacies contribute to an omnichannel approach that broadens access and supports patient engagement initiatives.
  • End Users: Designed for hospitals, ambulatory care, clinics, and homecare, each segment demands distinct usability, scalability, and infection control attributes.
  • Indications: Address asthma, chronic obstructive pulmonary disease, and cystic fibrosis—each with unique clinical and delivery requirements.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, with market penetration influenced by regulatory environments, reimbursement models, and healthcare infrastructure investments.
  • Key Technologies: Integrated sensors, real-time connectivity, propellant innovation, and recyclable materials are advancing device capabilities and sustainability practices.

Key Takeaways for Senior Decision-Makers

  • The convergence of digital therapeutics and inhalation therapy is empowering stakeholders to leverage real-world data for personalized interventions and improved outcomes.
  • Environmental regulations are accelerating the transition to eco-friendly inhaler and nebulizer designs, prompting manufacturers to prioritize lifecycle management and recyclable components.
  • Strategic alliances between pharmaceutical companies and technology firms are streamlining R&D cycles and enabling faster time-to-market for next-generation devices.
  • Omnichannel distribution is shifting patient engagement, placing emphasis on intuitive design, subscription fulfillment, and mobile health integration.
  • As demand continues to grow across emerging economies and mature markets alike, regional expertise is crucial for compliance and efficient market entry.

Tariff Impact on the Inhalers & Nebulizers Market

Recent U.S. tariffs introduced in 2025 have led manufacturers to reevaluate sourcing strategies, shift assembly operations, and cultivate relationships with regional contract manufacturing organizations. These actions have helped balance landed costs and maintain supply chain continuity. Companies are increasingly adopting value-based contracting to align reimbursement with clinical outcomes, while also focusing on nearshoring and supplier diversification to mitigate cost fluctuations and maintain pricing competitiveness.

Methodology & Data Sources

This report combines structured interviews with industry executives, clinicians, and procurement specialists. Robust secondary research covered manufacturer reports, regulatory filings, patent literature, and peer-reviewed journals. Quantitative data was validated through triangulation with public health statistics and expert workshops to ensure accuracy and actionable insight.

Why This Report Matters

  • Supports informed planning by detailing the market’s segmentation, major players, and evolving value creation levers.
  • Guides investment and partnership strategies with focused analysis on digital health integration, sustainability, and regulatory dynamics.
  • Reduces risk by highlighting supply chain considerations, tariff implications, and regional trends that influence product strategy and go-to-market execution.

Conclusion

The inhalers and nebulizers market is rapidly redefining standards in respiratory care. Senior leaders using these insights can confidently adapt to regulatory changes, strengthen their market positions, and foster sustainable growth within this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Inhalers & Nebulizers Market, by Device Type
8.1. Introduction
8.2. Inhalers
8.2.1. Dry Powder Inhaler
8.2.2. Metered Dose Inhaler
8.2.3. Soft Mist Inhaler
8.3. Nebulizers
8.3.1. Jet Nebulizer
8.3.2. Mesh Nebulizer
8.3.3. Ultrasonic Nebulizer
9. Inhalers & Nebulizers Market, by Therapeutic Class
9.1. Introduction
9.2. Anticholinergics
9.3. Bronchodilators
9.3.1. Long-Acting Beta-2 Agonists
9.3.2. Short-Acting Beta-2 Agonists
9.4. Combination Drugs
9.4.1. Ics Laba
9.4.2. Ics Laba Lama
9.4.3. Laba Lama
9.5. Corticosteroids
9.6. Mucolytics
10. Inhalers & Nebulizers Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Inhalers & Nebulizers Market, by End User
11.1. Introduction
11.2. Ambulatory Care Settings
11.3. Clinics
11.4. Homecare
11.5. Hospitals
12. Inhalers & Nebulizers Market, by Indication
12.1. Introduction
12.2. Asthma
12.3. Chronic Obstructive Pulmonary Disease
12.4. Cystic Fibrosis
13. Americas Inhalers & Nebulizers Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Inhalers & Nebulizers Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Inhalers & Nebulizers Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. Boehringer Ingelheim International GmbH
16.3.3. AstraZeneca plc
16.3.4. Teva Pharmaceutical Industries Ltd.
16.3.5. Novartis AG
16.3.6. Cipla Limited
16.3.7. Viatris Inc.
16.3.8. Koninklijke Philips N.V.
16.3.9. Omron Corporation
16.3.10. PARI GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INHALERS & NEBULIZERS MARKET MULTI-CURRENCY
FIGURE 2. INHALERS & NEBULIZERS MARKET MULTI-LANGUAGE
FIGURE 3. INHALERS & NEBULIZERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INHALERS & NEBULIZERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY LONG-ACTING BETA-2 AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY SHORT-ACTING BETA-2 AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ICS LABA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ICS LABA LAMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY LABA LAMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MUCOLYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 65. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 66. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 67. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 68. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 69. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 121. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 124. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 130. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 131. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 132. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 133. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 146. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 147. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 148. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 149. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 150. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 151. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 155. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 156. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 157. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 158. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 159. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 160. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SPAIN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 191. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 193. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 194. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 195. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 196. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 208. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 209. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 210. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 211. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 212. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 213. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 214. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. QATAR INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 218. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 220. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 221. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 223. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 247. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 248. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 249. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 250. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 253. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 254. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 255. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 256. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 257. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 258. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 259. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. TURKEY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 271. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 274. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 275. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 277. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 280. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 281. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 282. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 283. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 284. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 285. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 286. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. POLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 308. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 309. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 310. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 311. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 312. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 313. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 314. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 317. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 319. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 320. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 321. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 322. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 323. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 326. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 327. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 328. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 329. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 330. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY BRONCHODILATORS, 2018-2030 (USD MILLION)
TABLE 331. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY COMBINATION DRUGS, 2018-2030 (USD MILLION)
TABLE 332. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 333. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Inhalers & Nebulizers market report include:
  • GlaxoSmithKline plc
  • Boehringer Ingelheim International GmbH
  • AstraZeneca plc
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Cipla Limited
  • Viatris Inc.
  • Koninklijke Philips N.V.
  • Omron Corporation
  • PARI GmbH

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 14.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 38.72 Billion
Compound Annual Growth Rate22.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Smart Inhalers Market by Product Type, Application, Technology, Drug Type, End User, Distribution Channel, Operation Mode - Global Forecast to 2030 - Product Image

Smart Inhalers Market by Product Type, Application, Technology, Drug Type, End User, Distribution Channel, Operation Mode - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Drug Delivery Devices Market by Pre-Filled Syringes, Auto-Injectors, Inhalers, Pen Injectors, Insulin Pumps, Nebulizers, Transdermal Patches, Jet Injectors - Global Forecast to 2030 - Product Image

Drug Delivery Devices Market by Pre-Filled Syringes, Auto-Injectors, Inhalers, Pen Injectors, Insulin Pumps, Nebulizers, Transdermal Patches, Jet Injectors - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Respiratory Inhaler Devices Market Report 2025 - Product Image

Respiratory Inhaler Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Smart Inhaler Technology Market 2024-2028 - Product Image

Smart Inhaler Technology Market 2024-2028

  • Report
  • 169 Pages
  • Global
From
Respiratory Inhalers - Global Strategic Business Report - Product Image

Respiratory Inhalers - Global Strategic Business Report

  • Report
  • 620 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.